Disease: Basal cell carcinoma

LIBTAYO

Cemiplimab-rwlc 350mg/7mL (50mg/mL); per vial; soln for IV infusion after dilution.

ODOMZO

Sonidegib 200mg; caps.

ERIVEDGE

Vismodegib 150mg; caps.